CrossWork Midas Pre-IPO Fund, LLC

Background

CrossWork Midas Pre-IPO Fund, LLC is a venture capital firm specializing in late-stage, pre-IPO investments, particularly in companies leveraging artificial intelligence (AI) and advanced enterprise software. The firm's mission is to provide accredited investors with access to high-potential private companies poised for significant growth and public offerings. With a focus on companies valued at over $1 billion, CrossWork aims to deliver superior returns through strategic investments and value-added partnerships.

Key Strategic Focus

CrossWork's strategic focus centers on identifying and investing in late-stage companies with:

• Market Dominance: Companies with highly defensible positions and substantial market share.

• Strong Financials: Enterprises with revenues exceeding $100 million and robust growth trajectories.

• AI Integration: Businesses that either develop AI technologies or effectively leverage AI to enhance their operations.

The firm targets sectors such as AI, enterprise software, life sciences, and other emerging technologies, aiming to invest at significant discounts to the last institutional funding rounds to maximize potential returns.

Financials and Funding

CrossWork Midas Pre-IPO Fund has successfully raised capital from a diverse group of accredited investors, including former executives from leading companies like Stripe, Yahoo, Spirit Airlines, and Peabody Energy. The fund's portfolio comprises over 30 investments in late-stage AI and enterprise software companies, with a median last-round valuation substantially exceeding $1 billion. Notable portfolio companies include Stripe, Anthropic, Cerebras, SingleStore, and others identified as top candidates for IPOs in 2024.

Pipeline Development

CrossWork's investment pipeline focuses on companies within two years of an IPO or other liquidity events. The firm has participated in over $20 billion in IPO and M&A exits, with investments in companies such as Tealium, Cerebras, SambaNova, Tanium, Flexport, and DataRobot. These companies operate across various stages of development, with many nearing public offerings or acquisition milestones.

Technological Platform and Innovation

CrossWork distinguishes itself through a robust technological platform and innovative investment strategies:

• Proprietary Deal Sourcing: Leveraging an extensive network of over 1,000 venture capital and private equity contacts, CrossWork identifies and accesses high-caliber investment opportunities.

• Advisory Board Expertise: The firm benefits from the insights of a 70+ member advisory board, including former executives from Goldman Sachs, Stripe, and other industry leaders, providing critical diligence and strategic guidance.

• Accelerator Program: CrossWork enhances returns by allocating complimentary equity in emerging companies from its accelerator program to fund investors, offering unique return enhancements not available in most other funds.

Leadership Team

CrossWork's leadership comprises seasoned professionals with extensive experience in venture capital and investment banking:

• Steven Ogunro, Partner: Brings a background in investment banking and venture capital, focusing on identifying and managing high-potential investments.

• Sam Kelly, Vice President of Investments: Specializes in investment analysis and portfolio management, contributing to the firm's strategic investment decisions.

The advisory board includes notable figures such as:

• Former CEO of Spirit Airlines: Provides strategic insights into scaling businesses and operational excellence.

• Co-Inventor of Lipitor: Offers expertise in life sciences and pharmaceutical investments.

• Former CFO of Yahoo: Brings financial acumen and experience in managing large-scale technology companies.

Leadership Changes

In recent developments, CrossWork has expanded its advisory board to include accomplished medical doctors, scientists, and industry executives, enhancing its expertise in the life sciences sector. This strategic move aims to strengthen the firm's position in investing in cutting-edge medical technologies and biotech companies.

Competitor Profile

Market Insights and Dynamics

The pre-IPO investment market has demonstrated strong performance, with the 2020 IPO cohort offering a 117% increase between the last known private valuation and the public market debut. This trend underscores the potential for significant returns in late-stage venture capital investments.

Competitor Analysis

Key competitors in the pre-IPO investment space include:

• Sequoia Capital: Focuses on early and late-stage investments across various sectors, with a strong track record in technology and healthcare.

• Andreessen Horowitz: Invests in both early and late-stage companies, emphasizing technology and innovation-driven businesses.

• Tiger Global Management: Known for aggressive investments in late-stage technology companies, often participating in pre-IPO funding rounds.

These firms share a focus on high-growth technology companies but may differ in investment strategies, sector preferences, and levels of involvement in portfolio companies.

Strategic Collaborations and Partnerships

CrossWork has established significant collaborations to enhance its market position and innovation capacity:

• Advisory Board Expansion: Incorporating industry leaders from various sectors, including technology, life sciences, and finance, to provide strategic guidance and access to proprietary deal flow.

• Corporate Partnerships: Engaging with major corporations to support portfolio companies in scaling operations, accessing new markets, and achieving strategic objectives.

Operational Insights

CrossWork's strategic considerations include:

• Selective Investment Approach: Focusing on a limited number of high-quality investments to ensure thorough due diligence and active portfolio management.

• Value-Added Services: Providing portfolio companies with strategic introductions, team development support, and scaling advice to enhance growth prospects.

• Risk Mitigation: Employing a portfolio approach to diversify investments and reduce risk, while targeting companies with clear paths to liquidity events.

Strategic Opportunities and Future Directions

Looking ahead, CrossWork aims to:

• Expand Life Sciences Investments: Leveraging the expertise of its advisory board to identify and invest in promising biotech and medical technology companies.

• Enhance AI Portfolio: Continuing to invest in leading AI companies, particularly those nearing IPOs, to capitalize on the growing demand for AI solutions.

• Strengthen Strategic Partnerships: Building relationships with top-tier venture capital firms and corporate partners to access exclusive investment opportunities and support portfolio company growth.

Contact Information

• Website: crosswork.us

• Email: info@crosswork.us

• LinkedIn: CrossWork Midas Pre-IPO Fund

Note: Investments in private companies are illiquid and carry the risk of loss of all capital. Past results are no guarantee of future performance. No financial advice is provided herein.